Poliovirus Therapy for Recurrent Glioblastoma Has 3-Year Survival Rate of 21%

by SoP | Jul 4, 2018 | News | 0 comments

A new study reports a genetically modified poliovirus therapy has been shown to improve long term survival rates in recurrent glioblastoma brain cancer patients.